Drug Shortage Report for TEVA-IPRATROPIUM STERINEBS
Report ID | 8071 |
Drug Identification Number | 02216221 |
Brand name | TEVA-IPRATROPIUM STERINEBS |
Common or Proper name | IPRATROPIUM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | IPRATROPIUM BROMIDE |
Strength(s) | 0.025% |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 10X2ML |
ATC code | R03BB |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-04-21 |
Estimated end date | 2017-09-30 |
Actual end date | 2017-10-06 |
Shortage status | Resolved |
Updated date | 2017-10-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-10-10 | French | Compare |
v5 | 2017-10-10 | English | Compare |
v4 | 2017-09-19 | French | Compare |
v3 | 2017-09-19 | English | Compare |
v2 | 2017-04-25 | French | Compare |
v1 | 2017-04-25 | English | Compare |
Showing 1 to 6 of 6